Cargando…
Kynureninase Promotes Immunosuppression and Predicts Survival in Glioma Patients: In Silico Data Analyses of the Chinese Glioma Genome Atlas (CGGA) and of the Cancer Genome Atlas (TCGA)
Kynureninase (KYNU) is a kynurenine pathway (KP) enzyme that produces metabolites with immunomodulatory properties. In recent years, overactivation of KP has been associated with poor prognosis of several types of cancer, in particular by promoting the invasion, metastasis, and chemoresistance of ca...
Autores principales: | Pérez de la Cruz, Gonzalo, Pérez de la Cruz, Verónica, Navarro Cossio, Javier, Vázquez Cervantes, Gustavo Ignacio, Salazar, Aleli, Orozco Morales, Mario, Pineda, Benjamin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051585/ https://www.ncbi.nlm.nih.gov/pubmed/36986469 http://dx.doi.org/10.3390/ph16030369 |
Ejemplares similares
-
Bioinformatic Analysis of Kynurenine Pathway Enzymes and Their Relationship with Glioma Hallmarks
por: Vázquez Cervantes, Gustavo Ignacio, et al.
Publicado: (2022) -
Chinese Glioma Genome Atlas (CGGA): A Comprehensive Resource with Functional Genomic Data from Chinese Glioma Patients
por: Zhao, Zheng, et al.
Publicado: (2021) -
A lipid metabolism-related risk signature for patients with gliomas constructed with TCGA and CGGA data
por: Meng, Dingqiang, et al.
Publicado: (2022) -
High Levels of HIST1H2BK in Low-Grade Glioma Predicts Poor Prognosis: A Study Using CGGA and TCGA Data
por: Liu, Weidong, et al.
Publicado: (2020) -
Lactate-Loaded Nanoparticles Induce Glioma Cytotoxicity and Increase the Survival of Rats Bearing Malignant Glioma Brain Tumor
por: Chavarria, Víctor, et al.
Publicado: (2022)